SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Pablo S. Oliveira, José A. Rodrigues, Jamil A. Shibli, Adriano Piattelli, Giovanna Iezzi, Vittoria Perrotti, Influence of osteoporosis on the osteocyte density of human mandibular bone samples: a controlled histological human study, Clinical Oral Implants Research, 2015, 26, 1
  2. 2
    B. Hofstetter, S. Gamsjaeger, F. Varga, H. Dobnig, J. J. Stepan, H. Petto, I. Pavo, K. Klaushofer, E. P. Paschalis, Bone quality of the newest bone formed after two years of teriparatide therapy in patients who were previously treatment-naïve or on long-term alendronate therapy, Osteoporosis International, 2014, 25, 12, 2709

    CrossRef

  3. 3
    John A. Kanis, Rene Rizzoli, Cyrus Cooper, Jean-Yves Reginster, Challenges for the Development of Bone-Forming Agents in Europe, Calcified Tissue International, 2014, 94, 5, 469

    CrossRef

  4. 4
    Manabu Furuzawa, Huayue Chen, Shu Fujiwara, Kumiko Yamada, Kin-ya Kubo, Chewing ameliorates chronic mild stress-induced bone loss in senescence-accelerated mouse (SAMP8), a murine model of senile osteoporosis, Experimental Gerontology, 2014, 55, 12

    CrossRef

  5. 5
    Shuang Tan, Binbin Zhang, Xiaomei Zhu, Ping Ao, Huajie Guo, Weihong Yi, Guang-Qian Zhou, Deregulation of Bone Forming Cells in Bone Diseases and Anabolic Effects of Strontium-Containing Agents and Biomaterials, BioMed Research International, 2014, 2014, 1

    CrossRef

  6. 6
    Ulrike Kettenberger, Julien Ston, Eric Thein, Philip Procter, Dominique P. Pioletti, Does locally delivered Zoledronate influence peri-implant bone formation? – Spatio-temporal monitoring of bone remodeling in vivo, Biomaterials, 2014, 35, 37, 9995

    CrossRef

  7. 7
    N. Hassler, S. Gamsjaeger, B. Hofstetter, W. Brozek, K. Klaushofer, E. P. Paschalis, Effects of long-term alendronate treatment on postmenopausal osteoporosis bone material properties, Osteoporosis International, 2014,

    CrossRef

  8. 8
    Alan Šućur, Vedran Katavić, Tomislav Kelava, Zrinka Jajić, Natasa Kovačić, Danka Grčević, Induction of osteoclast progenitors in inflammatory conditions: key to bone destruction in arthritis, International Orthopaedics, 2014, 38, 9, 1893

    CrossRef

  9. 9
    Erik F. Eriksen, Tony M. Keaveny, Eileen R. Gallagher, John H. Krege, Literature review: The effects of teriparatide therapy at the hip in patients with osteoporosis, Bone, 2014, 67, 246

    CrossRef

  10. 10
    Pierre J. Marie, Osteoblast dysfunctions in bone diseases: from cellular and molecular mechanisms to therapeutic strategies, Cellular and Molecular Life Sciences, 2014,

    CrossRef

  11. 11
    N. Takahashi, T. Mizoguchi, Y. Nakamichi, Y. Kobayashi, M. Nakamura, N. Udagawa, W. Hofstetter, Reference Module in Biomedical Sciences, 2014,

    CrossRef

  12. 12
    Huayue Chen, Xiangrong Zhou, Hiroshi Fujita, Minoru Onozuka, Kin-Ya Kubo, Age-Related Changes in Trabecular and Cortical Bone Microstructure, International Journal of Endocrinology, 2013, 2013, 1

    CrossRef

  13. 13
    Koneni V. Sashidhara, Manoj Kumar, Vikram Khedgikar, Priyanka Kushwaha, Ram K. Modukuri, Abdhesh Kumar, Jyoti Gautam, Divya Singh, Balasubramaniam Sridhar, Ritu Trivedi, Discovery of Coumarin–Dihydropyridine Hybrids as Bone Anabolic Agents, Journal of Medicinal Chemistry, 2013, 56, 1, 109

    CrossRef

  14. 14
    Joseph P. Bidwell, Marta B. Alvarez, Mark Hood, Paul Childress, Functional Impairment of Bone Formation in the Pathogenesis of Osteoporosis: The Bone Marrow Regenerative Competence, Current Osteoporosis Reports, 2013, 11, 2, 117

    CrossRef

  15. 15
    Yan Wang, Bo Lin, In silico investigations of potential anabolic treatments in multiple myeloma-induced bone disease, Bone, 2013, 55, 1, 132

    CrossRef

  16. 16
    ERIK FINK ERIKSEN, JOHAN HALSE, METTE HAASE MOEN, New developments in the treatment of osteoporosis, Acta Obstetricia et Gynecologica Scandinavica, 2013, 92, 6
  17. 17
    Yongzheng He, Paul Childress, Mark Hood, Marta Alvarez, Melissa A. Kacena, Michael Hanlon, Bryce McKee, Joseph P. Bidwell, Feng-Chun Yang, Nmp4/CIZ Suppresses the Parathyroid Hormone Anabolic Window by Restricting Mesenchymal Stem Cell and Osteoprogenitor Frequency, Stem Cells and Development, 2013, 22, 3, 492

    CrossRef

  18. 18
    Min Pi, L. Darryl Quarles, Novel Bone Endocrine Networks Integrating Mineral and Energy Metabolism, Current Osteoporosis Reports, 2013, 11, 4, 391

    CrossRef

  19. 19
    Pierre J. Marie, Targeting integrins to promote bone formation and repair, Nature Reviews Endocrinology, 2013, 9, 5, 288

    CrossRef

  20. 20
    Hua Zhou, David W. Dempster, Osteoporosis, 2013,

    CrossRef

  21. 21
    Sundeep Khosla, Roberto Pacifici, Osteoporosis, 2013,

    CrossRef

  22. 22
    Nicola L. Fazzalari, Brianna L. Martin, Karen J. Reynolds, Tammy M. Cleek, Arash Badiei, Murk J. Bottema, A model for the change of cancellous bone volume and structure over time, Mathematical Biosciences, 2012, 240, 2, 132

    CrossRef

  23. 23
    Seham Salem Ahmed Abukhadir, Norazlina Mohamed, Suzana Makpol, Norliza Muhammad, Effects of Palm Vitamin E on Bone-Formation-Related Gene Expression in Nicotine-Treated Rats, Evidence-Based Complementary and Alternative Medicine, 2012, 2012, 1

    CrossRef

  24. 24
    Derya Aslan, Mille Dahl Andersen, Lene Bjerring Gede, Tine Kellemann de Franca, Sara Rubek Jørgensen, Peter Schwarz, Niklas Rye Jørgensen, Mechanisms for the bone anabolic effect of parathyroid hormone treatment in humans, Scandinavian Journal of Clinical & Laboratory Investigation, 2012, 72, 1, 14

    CrossRef

  25. 25
    Joan Otomo-Corgel, Osteoporosis and osteopenia: implications for periodontal and implant therapy, Periodontology 2000, 2012, 59, 1
  26. 26
    Olivia Fromigué, Julia Brun, Caroline Marty, Sophie Da Nascimento, Pascal Sonnet, Pierre J. Marie, Peptide-based activation of alpha5 integrin for promoting osteogenesis, Journal of Cellular Biochemistry, 2012, 113, 9
  27. 27
    José A Riancho, José L Hernández, Pharmacogenomics of osteoporosis: a pathway approach, Pharmacogenomics, 2012, 13, 7, 815

    CrossRef

  28. 28
    Zuzana Saidak, Pierre J. Marie, Strontium signaling: Molecular mechanisms and therapeutic implications in osteoporosis, Pharmacology & Therapeutics, 2012, 136, 2, 216

    CrossRef

  29. 29
    M.G. Goff, C.R. Slyfield, S.R. Kummari, E.V. Tkachenko, S.E. Fischer, Y.H. Yi, M.G. Jekir, T.M. Keaveny, C.J. Hernandez, Three-dimensional characterization of resorption cavity size and location in human vertebral trabecular bone, Bone, 2012, 51, 1, 28

    CrossRef

  30. 30
    Craig R Slyfield, Evgeniy V Tkachenko, David L Wilson, Christopher J Hernandez, Three-dimensional dynamic bone histomorphometry, Journal of Bone and Mineral Research, 2012, 27, 2
  31. 31
    Erik Fink Eriksen, Treatment of osteopenia, Reviews in Endocrine and Metabolic Disorders, 2012, 13, 3, 209

    CrossRef

  32. 32
    Ima Soelaiman, Norazlina Mohamed, Ahmad Shuid, Norliza Muhammad, Tocotrienols, 2012,

    CrossRef

  33. 33
    Lluis Pérez Edo, Alberto Alonso Ruiz, Daniel Roig Vilaseca, Alberto García Vadillo, Nuria Guañabens Gay, Pilar Peris, Antonio Torrijos Eslava, Chesús Beltrán Audera, Jordi Fiter Aresté, Luis Arboleya Rodríguez, Jenaro Graña Gil, Jordi Carbonell Abelló, Joan Miquel Nolla, Susana Holgado Pérez, Esteban Salas Heredia, Jaime Zubieta Tabernero, Javier Del Pino Montes, Josep Blanch i. Rubió, Manuel Caamaño Freire, Manuel Rodríguez Pérez, Santos Castañeda, Dacia Cerdá, Carmen Gómez Vaquero, Javier Calvo Catalá, Manel Ciria, Estíbaliz Loza, 2011 Up-Date of the Consensus Statement of the Spanish Society of Rheumatology on Osteoporosis, Reumatología Clínica (English Edition), 2011, 7, 6, 357

    CrossRef

  34. 34
    M. Sinnesael, F. Callewaert, M. Morreels, N. Kumar, R. Sitruk-Ware, K. Van Proeyen, P. Hespel, S. Boonen, F. Claessens, D. Vanderschueren, 7α-methyl-19-nortestosterone vs. testosterone implants for hypogonadal osteoporosis: a preclinical study in the aged male orchidectomized rat model, International Journal of Andrology, 2011, 34, 6pt2
  35. 35
    Xiaohua Zeng, Hao He, Liang Zhang, Yingying Wu, Yanying Wang, Ping Gong, A potential therapeutic approach to overload-induced bone loss around implant: Parathyroid hormone (PTH), Medical Hypotheses, 2011, 77, 5, 701

    CrossRef

  36. 36
    Lluís Pérez Edo, Alberto Alonso Ruiz, Daniel Roig Vilaseca, Alberto García Vadillo, Nuria Guañabens Gay, Pilar Peris, Antonio Torrijos Eslava, Chesús Beltrán Audera, Jordi Fiter Aresté, Luis Arboleya Rodríguez, Jenaro Graña Gil, Jordi Carbonell Abelló, Joan Miquel Nolla, Susana Holgado Pérez, Esteban Salas Heredia, Jaime Zubieta Tabernero, Javier Del Pino Montes, Josep Blanch i Rubió, Manuel Caamaño Freire, Manuel Rodríguez Pérez, Santos Castañeda, Dacia Cerdá, Carmen Gómez Vaquero, Javier Calvo Catalá, Manel Ciria, Estíbaliz Loza, Actualización 2011 del consenso Sociedad Española de Reumatología de osteoporosis, Reumatología Clínica, 2011, 7, 6, 357

    CrossRef

  37. 37
    Loredana Cavalli, Maria Luisa Brandi, Age- and gender-related macro- and micro-architecture changes in bone structure and implications for treatment, International Journal of Clinical Rheumatology, 2011, 6, 3, 359

    CrossRef

  38. 38
    Tarek Sibai, Elise F. Morgan, Thomas A. Einhorn, Anabolic Agents and Bone Quality, Clinical Orthopaedics and Related Research®, 2011, 469, 8, 2215

    CrossRef

  39. 39
    Yanfei L. Ma, Fernando Marin, Jan Stepan, Sophia Ish-Shalom, Rüdiger Möricke, Federico Hawkins, Georgios Kapetanos, María P. de la Peña, Jörn Kekow, Guillermo Martínez, Jorge Malouf, Qing Q. Zeng, Xiaohai Wan, Robert R. Recker, Comparative effects of teriparatide and strontium ranelate in the periosteum of iliac crest biopsies in postmenopausal women with osteoporosis, Bone, 2011, 48, 5, 972

    CrossRef

  40. 40
    R. Eastell, A. Rogers, X. Ni, J. H. Krege, Effects of raloxifene and alendronate on bone turnover as assessed by procollagen type I N-terminal propeptide, Osteoporosis International, 2011, 22, 6, 1927

    CrossRef

  41. 41
    Trong-Tuan Dao, Kwang-Youl Lee, Hyung-Min Jeong, Phi-Hung Nguyen, Tien Lam Tran, Phuong-Thien Thuong, Bich-Thu Nguyen, Won-Keun Oh, ent-Kaurane Diterpenoids fromCroton tonkinensisStimulate Osteoblast Differentiation, Journal of Natural Products, 2011, 74, 12, 2526

    CrossRef

  42. 42
    Tuija M Mikkola, Ari Heinonen, Vuokko Kovanen, Sulin Cheng, Urho M Kujala, Harri Suominen, Markku Alén, Jukka Puolakka, Carina Ankarberg-Lindgren, Paula HA Ronkainen, Markku Koskenvuo, Jaakko Kaprio, Taina Rantanen, Sarianna Sipilä, Influence of long-term postmenopausal hormone-replacement therapy on estimated structural bone strength: A study in discordant monozygotic twins, Journal of Bone and Mineral Research, 2011, 26, 3
  43. 43
    S. Vasikaran, R. Eastell, O. Bruyère, A. J. Foldes, P. Garnero, A. Griesmacher, M. McClung, H. A. Morris, S. Silverman, T. Trenti, D. A. Wahl, C. Cooper, J. A. Kanis, Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards, Osteoporosis International, 2011, 22, 2, 391

    CrossRef

  44. 44
    Gabriella Dvorak, Christoph Arnhart, Simone Heuberer, Christian D. Huber, Georg Watzek, Reinhard Gruber, Peri-implantitis and late implant failures in postmenopausal women: a cross-sectional study, Journal of Clinical Periodontology, 2011, 38, 10
  45. 45
    C. Lukas, P. Kollmannsberger, D. Ruffoni, P. Roschger, P. Fratzl, R. Weinkamer, The Heterogeneous Mineral Content of Bone—Using Stochastic Arguments and Simulations to Overcome Experimental Limitations, Journal of Statistical Physics, 2011, 144, 2, 316

    CrossRef

  46. 46
    Alexander Fuegl, Stefan Tangl, Claudia Keibl, Georg Watzek, Heinz Redl, Reinhard Gruber, The impact of ovariectomy and hyperglycemia on graft consolidation in rat calvaria, Clinical Oral Implants Research, 2011, 22, 5
  47. 47
    Ioannis Charopoulos, Steve Orme, Peter V Giannoudis, The role and efficacy of denosumab in the treatment of osteoporosis: an update, Expert Opinion on Drug Safety, 2011, 10, 2, 205

    CrossRef

  48. 48
    H. Chen, X. Zhou, S. Shoumura, S. Emura, Y. Bunai, Age- and gender-dependent changes in three-dimensional microstructure of cortical and trabecular bone at the human femoral neck, Osteoporosis International, 2010, 21, 4, 627

    CrossRef

  49. 49
    L. J. Melton, D. Christen, B. L. Riggs, S. J. Achenbach, R. Müller, G. H. van Lenthe, S. Amin, E. J. Atkinson, S. Khosla, Assessing forearm fracture risk in postmenopausal women, Osteoporosis International, 2010, 21, 7, 1161

    CrossRef

  50. 50
    Teun M. Post, Serge C.L.M. Cremers, Thomas Kerbusch, Meindert Danhof, Bone Physiology, Disease and Treatment, Clinical Pharmacokinetics, 2010, 49, 2, 89

    CrossRef

  51. 51
    Reinhard Gruber, Cell biology of osteoimmunology, Wiener Medizinische Wochenschrift, 2010, 160, 17-18, 438

    CrossRef

  52. 52
    B.L. Clarke, Comparative Effects of Teriparatide and Strontium Ranelate on Bone Biopsies and Biochemical Markers of Bone Turnover in Postmenopausal Women With Osteoporosis, Yearbook of Endocrinology, 2010, 2010, 226

    CrossRef

  53. 53
    Robert L. Jilka, Maria Almeida, Elena Ambrogini, Li Han, Paula K. Roberson, Robert S. Weinstein, Starros C. Manolagas, Decreased oxidative stress and greater bone anabolism in the aged, when compared to the young, murine skeleton with parathyroid hormone administration, Aging Cell, 2010, 9, 5
  54. 54
    C. Gómez Alonso, Indicaciones de la densitometría ósea. Pruebas diagnósticas radiológicas en patología ósea, Medicine - Programa de Formación Médica Continuada Acreditado, 2010, 10, 60, 4173

    CrossRef

  55. 55
    Peter Pivonka, Svetlana V. Komarova, Mathematical modeling in bone biology: From intracellular signaling to tissue mechanics, Bone, 2010, 47, 2, 181

    CrossRef

  56. 56
    Reinhard Gruber, Osteoporose – Risikofaktor in der Zahnheilkunde?, Stomatologie, 2010, 107, 4, 55

    CrossRef

  57. 57
    Peter Pivonka, Jan Zimak, David W. Smith, Bruce S. Gardiner, Colin R. Dunstan, Natalie A. Sims, T. John Martin, Gregory R. Mundy, Theoretical investigation of the role of the RANK–RANKL–OPG system in bone remodeling, Journal of Theoretical Biology, 2010, 262, 2, 306

    CrossRef

  58. 58
    Ahmad Nazrun Shuid, Zulfadli Mehat, Norazlina Mohamed, Norliza Muhammad, Ima Nirwana Soelaiman, Vitamin E exhibits bone anabolic actions in normal male rats, Journal of Bone and Mineral Metabolism, 2010, 28, 2, 149

    CrossRef

  59. 59
    Mahmoud Tabbal, Ghada El-Hajj Fuleihan, Osteoporosis in Men, 2010,

    CrossRef

  60. 60
    Olivia Fromigué, Eric Haÿ, Alain Barbara, Christophe Petrel, Elisabeth Traiffort, Martial Ruat, Pierre J. Marie, Calcium sensing receptor-dependent and receptor-independent activation of osteoblast replication and survival by strontium ranelate, Journal of Cellular and Molecular Medicine, 2009, 13, 8b, 2189

    CrossRef

  61. 61
    Olivia Fromigué, Eric Haÿ, Alain Barbara, Christophe Petrel, Elisabeth Traiffort, Martial Ruat, Pierre J. Marie, Calcium sensing receptor-dependent and receptor-independent activation of osteoblast replication and survival by strontium ranelate, Journal of Cellular and Molecular Medicine, 2009, 13, 8b
  62. 62
    E Michael Lewiecki, Denosumab for the treatment of postmenopausal osteoporosis, Women's Health, 2009, 5, 1, 15

    CrossRef

  63. 63
    T. Mizoguchi, A. Muto, N. Udagawa, A. Arai, T. Yamashita, A. Hosoya, T. Ninomiya, H. Nakamura, Y. Yamamoto, S. Kinugawa, M. Nakamura, Y. Nakamichi, Y. Kobayashi, S. Nagasawa, K. Oda, H. Tanaka, M. Tagaya, J. M. Penninger, M. Ito, N. Takahashi, Identification of cell cycle-arrested quiescent osteoclast precursors in vivo, The Journal of Cell Biology, 2009, 184, 4, 541

    CrossRef

  64. 64
    Piet Geusens, Strategies for treatment to prevent fragility fractures in postmenopausal women, Best Practice & Research Clinical Rheumatology, 2009, 23, 6, 727

    CrossRef

  65. 65
    N. A. T. Hamdy, Strontium ranelate improves bone microarchitecture in osteoporosis, Rheumatology, 2009, 48, suppl 4, iv9

    CrossRef

  66. 66
    S. D. Bain, C. Jerome, V. Shen, I. Dupin-Roger, P. Ammann, Strontium ranelate improves bone strength in ovariectomized rat by positively influencing bone resistance determinants, Osteoporosis International, 2009, 20, 8, 1417

    CrossRef

  67. 67
    Bart L. Clarke, Sundeep Khosla, Pharmacology and Therapeutics, 2009,

    CrossRef

  68. 68
    Sum Lam, Katerina Zouzias, <b>Strontium Ranelate for the Management of Osteoporosis</b>, The Consultant Pharmacist, 2008, 23, 7, 531

    CrossRef

  69. 69
    Xiao Qing Liu, Hai Yan Chen, Xiao Yan Tian, Rebecca B. Setterberg, Mei Li, Webster S. Jee, Alfacalcidol treatment increases bone mass from anticatabolic and anabolic effects on cancellous and cortical bone in intact female rats, Journal of Bone and Mineral Metabolism, 2008, 26, 5, 425

    CrossRef

  70. 70
    Richard Eastell, Rosemary A. Hannon, Biomarkers of bone health and osteoporosis risk, Proceedings of the Nutrition Society, 2008, 67, 02, 157

    CrossRef

  71. 71
    Maria-Theresa Krauth, Alexander Fügl, Reinhard Gruber, Bisphosphonat-assoziierte Osteonekrosen des Kieferknochens, Wiener klinische Wochenschrift, 2008, 120, 15-16, 467

    CrossRef

  72. 72
    Joshua A. MacNeil, Steven K. Boyd, Bone strength at the distal radius can be estimated from high-resolution peripheral quantitative computed tomography and the finite element method, Bone, 2008, 42, 6, 1203

    CrossRef

  73. 73
    R. K. Fuchs, S. J. Warden, Combination Therapy Using Exercise and Pharmaceutical Agents to Optimize Bone Health, Clinical Reviews in Bone and Mineral Metabolism, 2008, 6, 1-2, 37

    CrossRef

  74. 74
    Piet P Geusens, Christian H Roux, David M Reid, Willem F Lems, Silvano Adami, Jonathan D Adachi, Philip N Sambrook, Kenneth G Saag, Nancy E Lane, Marc C Hochberg, Drug Insight: choosing a drug treatment strategy for women with osteoporosis—an evidence-based clinical perspective, Nature Clinical Practice Rheumatology, 2008, 4, 5, 240

    CrossRef

  75. 75
    B.L. Clarke, Effects of Teriparatide and Alendronate on Vertebral Strength as Assessed by Finite Element Modeling of QCT Scans in Women With Osteoporosis, Yearbook of Endocrinology, 2008, 2008, 219

    CrossRef

  76. 76
    Roberto Pacifici, Estrogen deficiency, T cells and bone loss, Cellular Immunology, 2008, 252, 1-2, 68

    CrossRef

  77. 77
    Monique E Arlot, Yebin Jiang, Harry K Genant, Jenny Zhao, Brigitte Burt-Pichat, Jean-Paul Roux, Pierre D Delmas, Pierre J Meunier, Histomorphometric and μCT Analysis of Bone Biopsies From Postmenopausal Osteoporotic Women Treated With Strontium Ranelate, Journal of Bone and Mineral Research, 2008, 23, 2
  78. 78
    N. Patano, L. Mancini, M. P. Settanni, M. Strippoli, G. Brunetti, G. Greco, R. Tamma, R. Vergari, F. Sardelli, A. Koverech, S. Colucci, A. Zallone, M. Grano, l-Carnitine Fumarate and Isovaleryl-l-Carnitine Fumarate Accelerate the Recovery of Bone Volume/Total Volume Ratio after Experimetally Induced Osteoporosis in Pregnant Mice, Calcified Tissue International, 2008, 82, 3, 221

    CrossRef

  79. 79
    Peter Pivonka, Jan Zimak, David W. Smith, Bruce S. Gardiner, Colin R. Dunstan, Natalie A. Sims, T. John Martin, Gregory R. Mundy, Model structure and control of bone remodeling: A theoretical study, Bone, 2008, 43, 2, 249

    CrossRef

  80. 80
    Markus Müller, Peter Pietschmann, Parathyroid hormone analogues in the therapy of osteoporosis, Wiener klinische Wochenschrift, 2008, 120, 11-12, 321

    CrossRef

  81. 81
    H. Chen, S. Shoumura, S. Emura, Y. Bunai, Regional variations of vertebral trabecular bone microstructure with age and gender, Osteoporosis International, 2008, 19, 10, 1473

    CrossRef

  82. 82
    K. Venken, F. Callewaert, S. Boonen, D. Vanderschueren, Sex hormones, their receptors and bone health, Osteoporosis International, 2008, 19, 11, 1517

    CrossRef

  83. 83
    Roland D Chapurlat, Single annual injectable treatment for postmenopausal osteoporosis, Expert Opinion on Drug Delivery, 2008, 5, 5, 583

    CrossRef

  84. 84
    Matthew R. Allen, Surface-specific Bone Formation Effects of Osteoporosis Pharmacological Treatments, Clinical Reviews in Bone and Mineral Metabolism, 2008, 6, 1-2, 62

    CrossRef

  85. 85
    E Michael Lewiecki, Zoledronic acid in the management of osteoporosis: the HORIZON trials, Therapy, 2008, 5, 6, 829

    CrossRef

  86. 86
    David W. Dempster, Principles of Bone Biology, 2008,

    CrossRef

  87. 87
    Barbara Weicht, Philipp Maitz, Barbara Kandler, Michael B. Fischer, Georg Watzek, Reinhard Gruber, Activated platelets positively regulate RANKL-mediated osteoclast differentiation, Journal of Cellular Biochemistry, 2007, 102, 5
  88. 88
    Jean D. Sibonga, Peter R. Cavanagh, Thomas F. Lang, Adrian D. LeBlanc, Victor S. Schneider, Linda C. Shackelford, Scott M. Smith, Laurence Vico, Adaptation of the Skeletal System During Long-Duration Spaceflight, Clinical Reviews in Bone and Mineral Metabolism, 2007, 5, 4, 249

    CrossRef

  89. 89
    E Michael Lewiecki, Bazedoxifene and bazedoxifene combined with conjugated estrogens for the management of postmenopausal osteoporosis, Expert Opinion on Investigational Drugs, 2007, 16, 10, 1663

    CrossRef

  90. 90
    Rick Bransford, Elisabeth Goergens, Julie Briody, Negin Amanat, Andrew Cree, David Little, Effect of zoledronic acid in an L6–L7 rabbit spine fusion model, European Spine Journal, 2007, 16, 4, 557

    CrossRef

  91. 91
    F. Bauss, D.W. Dempster, Effects of ibandronate on bone quality: Preclinical studies, Bone, 2007, 40, 2, 265

    CrossRef

  92. 92
    Esteban Jódar-Gimeno, Full length parathyroid hormone (1?84) in the treatment of osteoporosis in postmenopausal women, Clinical Interventions in Aging, 2007, 2, 1, 163

    CrossRef

  93. 93
    Robert L. Jilka, Molecular and cellular mechanisms of the anabolic effect of intermittent PTH, Bone, 2007, 40, 6, 1434

    CrossRef

  94. 94
    Negin Amanat, Michelle McDonald, Craig Godfrey, Lynne Bilston, David Little, Optimal Timing of a Single Dose of Zoledronic Acid to Increase Strength in Rat Fracture Repair, Journal of Bone and Mineral Research, 2007, 22, 6
  95. 95
    R. Peled, D. Dahan, R. Endevelt, D. R. Shahar, Osteoporosis among Ethiopian immigrant women: a risk analysis, Archives of Osteoporosis, 2007, 2, 1-2, 45

    CrossRef

  96. 96
    Manuel Muñoz-Torres, Esteban Jódar Gimeno, Osteoporosis: informe del Grupo de Trabajo de Metabolismo Mineral Óseo de la SEEN, Endocrinología y Nutrición, 2007, 54, 1, 53

    CrossRef

  97. 97
    Costas Giaginis, Anna Tsantili-Kakoulidou, Stamatios Theocharis, Peroxisome proliferator-activated receptors (PPARs) in the control of bone metabolism, Fundamental & Clinical Pharmacology, 2007, 21, 3
  98. 98
    Mariona Bustamante, Xavier Nogués, Lídia Águeda, Susana Jurado, Anke Wesselius, Enrique Cáceres, Ramon Carreras, Manel Ciria, Leonardo Mellibovsky, Susana Balcells, Adolfo Díez-Pérez, Daniel Grinberg, Promoter 2 -1025 T/C Polymorphism in the RUNX2 Gene Is Associated with Femoral Neck BMD in Spanish Postmenopausal Women, Calcified Tissue International, 2007, 81, 4, 327

    CrossRef

  99. 99
    Melek Eda Ertorer, Okan Bakiner, Inan Anaforoglu, Nurzen Sezgin, Nilgun Guvener Demirag, Neslihan Bascil Tutuncu, Serum Osteoprotegerin Concentration with Strontium Ranelate Treatment for Postmenopausal Osteoporosis: An Open, Prospective Study, Current Therapeutic Research, 2007, 68, 4, 217

    CrossRef

  100. 100
    Sakae Tanaka, Signaling Axis in Osteoclast Biology and Therapeutic Targeting in the RANKL/RANK/OPG System, American Journal of Nephrology, 2007, 27, 5, 466

    CrossRef

  101. 101
    Richard Eastell, Skeletal Health in Adulthood, Hormone Research, 2007, 67, 1, 23

    CrossRef

  102. 102
    Pierre J. Marie, Strontium ranelate: New insights into its dual mode of action, Bone, 2007, 40, 5, S5

    CrossRef

  103. 103
    Julian MR Mathoo, Lisa Becker, Dinesh Kumbhare, Jonathan D Adachi, Therapeutic advances in the treatment of osteoporosis, Expert Opinion on Therapeutic Patents, 2007, 17, 3, 277

    CrossRef

  104. 104
    Rlchard Eastell, Rosemary A. Hannon, Treatment of the Postmenopausal Woman, 2007,

    CrossRef

  105. 105
    HP Rang, MM Dale, JM Ritter, RJ Flower, Rang & Dale's Pharmacology, 2007,

    CrossRef

  106. 106
    A. W. C. Kung, E. G. Pasion, M. Sofiyan, E. M. C. Lau, B. K. Tay, K. S. Lam, K. Wilawan, B. Ongphiphadhanakul, D. Thiebaud, A comparison of teriparatide and calcitonin therapy in postmenopausal Asian women with osteoporosis: a 6-month study*, Current Medical Research and Opinion, 2006, 22, 5, 929

    CrossRef

  107. 107
    Hua Zhu Ke, D Todd Crawford, Hong Qi, Hollis A Simmons, Thomas A Owen, Vishwas M Paralkar, Mei Li, Bihong Lu, William A Grasser, Kimberly O Cameron, Bruce A Lefker, Paul DaSilva-Jardine, Dennis O Scott, Qing Zhang, Xiao Yan Tian, Webster SS Jee, Thomas A Brown, David D Thompson, A Nonprostanoid EP4 Receptor Selective Prostaglandin E2 Agonist Restores Bone Mass and Strength in Aged, Ovariectomized Rats, Journal of Bone and Mineral Research, 2006, 21, 4
  108. 108
    Mitsuhiko Takahashi, Kiminori Yukata, Yoshito Matsui, Aziz Abbaspour, Shinjiro Takata, Natsuo Yasui, Bisphosphonate modulates morphological and mechanical properties in distraction osteogenesis through inhibition of bone resorption, Bone, 2006, 39, 3, 573

    CrossRef

  109. 109
    R Graham G Russell, Belen Espina, Philippa Hulley, Bone biology and the pathogenesis of osteoporosis, Current Opinion in Rheumatology, 2006, 18, Suppl 1, S3

    CrossRef

  110. 110
    Dominique D. Pierroz, Mary L. Bouxsein, René Rizzoli, Serge L. Ferrari, Combined treatment with a β-blocker and intermittent PTH improves bone mass and microarchitecture in ovariectomized mice, Bone, 2006, 39, 2, 260

    CrossRef

  111. 111
    E Michael Lewiecki, Denosumab: a promising drug for the prevention and treatment of osteoporosis, Women's Health, 2006, 2, 4, 517

    CrossRef

  112. 112
    Sundeep Khosla, B Lawrence Riggs, Elizabeth J Atkinson, Ann L Oberg, Lisa J McDaniel, Margaret Holets, James M Peterson, L Joseph Melton, Effects of Sex and Age on Bone Microstructure at the Ultradistal Radius: A Population-Based Noninvasive In Vivo Assessment, Journal of Bone and Mineral Research, 2006, 21, 1
  113. 113
    Reinhard Gruber, Hannjörg Koch, Bruce A. Doll, Florian Tegtmeier, Thomas A. Einhorn, Jeffrey O. Hollinger, Fracture healing in the elderly patient, Experimental Gerontology, 2006, 41, 11, 1080

    CrossRef

  114. 114
    Laura S. Gregory, Wendy L. Kelly, Robert C. Reid, David P. Fairlie, Mark R. Forwood, Inhibitors of cyclo-oxygenase-2 and secretory phospholipase A2 preserve bone architecture following ovariectomy in adult rats, Bone, 2006, 39, 1, 134

    CrossRef

  115. 115
    Núria Guañabens Gay, Nuevas dianas terapéuticas en el tratamiento de la osteoporosis, Reumatología Clínica, 2006, 2, 6, 281

    CrossRef

  116. 116
    Ambrish Mithal, Nidhi Malhotra, Osteoporosis: Key Issues in Management, Apollo Medicine, 2006, 3, 2, 189

    CrossRef

  117. 117
    L. Harbouche, I. Shahapuni, M. Monge, B. Araar, K. Rahmouni, R. Oprisiu, J. Mansour, C. Presne, I. El Esper, F. Boitte, N. El Esper, P. Morinière, M Brazier, Z. Massy, G. Choukroun, A. Fournier, Place des nouveaux traitements de l'ostéodystrophie rénale : dérivés 1α-hydroxylés de la vitamine D « non hypercalcémiants », complexants non calciques, non magnésiens et non aluminiques des phosphates, et calcimimétiques, Immuno-analyse & Biologie Spécialisée, 2006, 21, 1, 9

    CrossRef

  118. 118
    B Lawrence Riggs, L Joseph Melton, Richard A Robb, Jon J Camp, Elizabeth J Atkinson, Ann L Oberg, Peggy A Rouleau, Cynthia H McCollough, Sundeep Khosla, Mary L Bouxsein, Population-Based Analysis of the Relationship of Whole Bone Strength Indices and Fall-Related Loads to Age- and Sex-Specific Patterns of Hip and Wrist Fractures, Journal of Bone and Mineral Research, 2006, 21, 2
  119. 119
    E Michael Lewiecki, Prevention of osteoporotic fractures, Aging Health, 2006, 2, 4, 649

    CrossRef

  120. 120
    E Michael Lewiecki, RANK ligand inhibition with denosumab for the management of osteoporosis, Expert Opinion on Biological Therapy, 2006, 6, 10, 1041

    CrossRef

  121. 121
    Stavros C. Manolagas, Robert L. Jilka, Stavroula Kousteni, Teresita Bellido, Robert S. Weinstein, Charles A. O’Brien, Lilian Plotkin, Li Han, Response to Windahl et al., Journal of Clinical Investigation, 2006, 116, 11, 2834

    CrossRef

  122. 122
    P.J. Marie, Strontium ranelate: A physiological approach for optimizing bone formation and resorption, Bone, 2006, 38, 2, 10

    CrossRef

  123. 123
    Yanfei L Ma, Qingqiang Zeng, David W Donley, Louis-Georges Ste-Marie, J Christopher Gallagher, Gail P Dalsky, Robert Marcus, Erik Fink Eriksen, Teriparatide Increases Bone Formation in Modeling and Remodeling Osteons and Enhances IGF-II Immunoreactivity in Postmenopausal Women With Osteoporosis, Journal of Bone and Mineral Research, 2006, 21, 6
  124. 124
    Ego Seeman, Gordon J Strewler, Clinical and basic research papers – April 2005 selections, BoneKEy-Osteovision, 2005, 2, 5, 1

    CrossRef

  125. 125
    Ego Seeman, Gordon J Strewler, Clinical and basic research papers – January 2005 selections, BoneKEy-Osteovision, 2005, 2, 2, 1

    CrossRef

  126. 126
    S. Schaller, K. Henriksen, P. Hoegh-Andersen, B.C. Søndergaard, E.U. Sumer, L.B. Tanko, P. Qvist, M.A. Karsdal, In Vitro, Ex Vivo, andIn VivoMethodological Approaches for Studying Therapeutic Targets of Osteoporosis and Degenerative Joint Diseases: How Biomarkers Can Assist?, ASSAY and Drug Development Technologies, 2005, 3, 5, 553

    CrossRef

  127. 127
    Richard Eastell, Management of Bone Health in Postmenopausal Women, Hormone Research, 2005, 64, 2, 76

    CrossRef

  128. 128
    David G Little, Michelle McDonald, Rick Bransford, Craig B Godfrey, Negin Amanat, Manipulation of the Anabolic and Catabolic Responses With OP-1 and Zoledronic Acid in a Rat Critical Defect Model, Journal of Bone and Mineral Research, 2005, 20, 11
  129. 129
    Piet Geusens, David Reid, Newer drug treatments: Their effects on fracture prevention, Best Practice & Research Clinical Rheumatology, 2005, 19, 6, 983

    CrossRef

  130. 130
    Jackie A. Clowes, B. Lawrence Riggs, Sundeep Khosla, The role of the immune system in the pathophysiology of osteoporosis, Immunological Reviews, 2005, 208, 1
  131. 131
    Han Bok Kwak, Hye-Mi Jin, Hyunil Ha, Mi-Jin Kang, Seung Bok Lee, Hong-Hee Kim, Zang Hee Lee, Tumor necrosis factor-α induces differentiation of human peripheral blood mononuclear cells into osteoclasts through the induction of p21(WAF1/Cip1), Biochemical and Biophysical Research Communications, 2005, 330, 4, 1080

    CrossRef

  132. 132
    Georges Rawadi, Sergio Roman-Roman, Wnt signalling pathway: a new target for the treatment of osteoporosis, Expert Opinion on Therapeutic Targets, 2005, 9, 5, 1063

    CrossRef

  133. 133
    David R. Haynes, David M. Findlay, Bone Resorption, Wiley Encyclopedia of Biomedical Engineering,
  134. 134
    Ben-Hur Albergaria, Brenda Nazaré Gomes Silva, Álvaro N Atallah, Virginia Fernandes Moça Trevisani, Intravenous zoledronate for postmenopausal osteoporosis, The Cochrane Library,
  135. 135
    Beiyu Wang, Ying Song, Zhou Xiang, Taixiang Wu, Statins for osteoporosis in postmenopausal women, The Cochrane Library,
  136. 136
    S O'Donnell, A Cranney, GA Wells, JD Adachi, JY Reginster, Strontium ranelate for preventing and treating postmenopausal osteoporosis, The Cochrane Library,